The biology and pathology of vitamin D control in bone

Journal of Cellular Biochemistry

Volumn 111, Issue 1, 2010, Pages 7-13

  Bell, Taison D ^a   Demay, Marie B ^a   Burnett Bowie, Sherri Ann M ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Bone; Osteomalacia; Rickets; Vitamin D

Indexed keywords

RETINOID X RECEPTOR; VITAMIN D; VITAMIN D RECEPTOR;

BONE DENSITY; BONE DISEASE; CULTURAL FACTOR; DIET; DNA SEQUENCE; GENE EXPRESSION; GENE TARGETING; HOMEOSTASIS; HUMAN; NONHUMAN; OSTEOLYSIS; PRIORITY JOURNAL; REVIEW; SKELETON; ULTRAVIOLET RADIATION; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

ANIMALS; BONE AND BONES; CLINICAL TRIALS AS TOPIC; GENE EXPRESSION REGULATION; HUMANS; RECEPTORS, CALCITRIOL; RETINOID X RECEPTORS; RICKETS; VITAMIN D;

ANIMALIA;

EID: 77957171079     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22661     Document Type: Review

References (97)

1. Adami S, Giannini S, Bianchi G, Sinigaglia L, Di Munno O, Fiore CE, Minisola S, Rossini M. 2009. Vitamin D status and response to treatment in post-menopausal osteoporosis. Osteoporos Int 20:239-244.
2. Adams JS, Hewison M. 2010. Update in vitamin D. J Clin Endocrinol Metab 95:471-478.
3. Adams CS, Mansfield K, Perlot RL, Shapiro IM. 2001. Matrix regulation of skeletal cell apoptosis. Role of calcium and phosphate ions. J Biol Chem 276:20316-20322. (Pubitemid 33651751)
4. Amling M, Priemel M, Holzmann T, Chapin K, Rueger JM, Baron R, Demay MB. 1999. Rescue of the skeletal phenotype of vitamin D receptor-ablated mice in the setting of normal mineral ion homeostasis: Formal histomorphometric and biomechanical analyses. Endocrinology 140:4982-4987.
5. Araujo AB, Travison TG, Esche GR, Holick MF, Chen TC, McKinlay JB. 2009. Serum 25-hydroxyvitamin D and bone mineral density among Hispanic men. Osteoporos Int 20:245-255.
6. Avenell A, Gillespie WJ, Gillespie LD, O'Connell D. 2009. Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. Cochrane Database Syst Rev CD000227.
7. Balsan S, Garabedian M, Larchet M, Gorski A-M, Cournot G, Tau C, Bourdeau A, Silve C, Ricour C. 1986. Long-term nocturnal calcium infusions can cure rickets and promote normal mineralization in hereditary resistance to 1,25- dihydroxyvitamin D. J Clin Invest 77:1661-1667.
8. Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, Staehelin HB, Bazemore MG, Zee RY, Wong JB. 2004a. Effect of Vitamin D on falls: A meta-analysis. JAMA 291:1999-2006.
9. Bischoff-Ferrari HA, Dietrich T, Orav EJ, Dawson-Hughes B. 2004b. Positive association between 25-hydroxy vitamin D levels and bone mineral density: A population-based study of younger and older adults. Am J Med 116:634-639. (Pubitemid 38490539)
10. Bischoff-Ferrari HA, Willett WC, Wong JB, Giovannucci E, Dietrich T, Dawson-Hughes B. 2005. Fracture prevention with vitamin D supplementation: A meta-analysis of randomized controlled trials. JAMA 293:2257-2264.
11. Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, Orav JE, Stuck AE, Theiler R, Wong JB, Egli A, Kiel DP, Henschkowski J. 2009a. Fall prevention with supplemental and active forms of vitamin D: A meta-analysis of randomised controlled trials. Br Med J 339:b3692.
12. Bischoff-Ferrari HA, Kiel DP, Dawson-Hughes B, Orav JE, Li R, Spiegelman D, Dietrich T, Willett WC. 2009b. Dietary calcium and serum 25-hydroxyvitamin D status in relation to BMD among U.S. adults. J Bone Miner Res 24:935-942.
13. Bouillon R, Bischoff-Ferrari H, Willett W. 2008. Vitamin D and health: Perspectives from mice and man. J Bone Miner Res 23:974-979. (Pubitemid 351915717)
14. Boyan BD, Wong KL, Wang L, Yao H, Guldberg RE, Drab M, Jo H, Schwartz Z. 2006. Regulation of growth plate chondrocytes by 1,25-dihydroxyvitamin D3 requires caveolae and caveolin-1. J Bone Miner Res 21:1637-1647.
15. Boyle IT, Miravet L, Gray RW, Holick MF, Deluca HF. 1972. The response of intestinal calcium transport to 25-hydroxy and 1,25-dihydroxy vitamin D in nephrectomized rats. Endocrinology 90:605-608.
16. Cauley JA, Lacroix AZ, Wu L, Horwitz M, Danielson ME, Bauer DC, Lee JS, Jackson RD, Robbins JA, Wu C, Stanczyk FZ, LeBoff MS, Wactawski-Wende J, Sarto G, Ockene J, Cummings SR. 2008. Serum 25-hydroxyvitamin D concentrations and risk for hip fractures. Ann Intern Med 149:242-250.
17. Cauley JA, Parimi N, Ensrud KE, Bauer DC, Cawthon PM, Cummings SR, Hoffman AR, Shikany JM, Barrett-Connor E, Orwoll E. 2010. Serum 25 hydroxyvitamin D and the risk of hip and non-spine fractures in older men. J Bone Miner Res 25:545-553.
18. Chang W, Tu C, Pratt S, Chen TH, Shoback D. 2002. Extracellular Ca(2+)-sensing receptors modulate matrix production and mineralization in chondrogenic RCJ3.1C5.18 cells. Endocrinology 143:1467-1474.
19. Chapuy MC, Arlot ME, Duboeuf F, Brun J, Crouzet B, Arnaud S, Delmas PD, Meunier PJ. 1992. Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med 327:1637-1642.
20. Chen P, Hu P, Xie D, Qin Y, Wang F, Wang H. 2009. Meta-analysis of vitamin D, calcium and the prevention of breast cancer. Breast Cancer Res Treat.
21. Cianferotti L, Demay MB. 2007. VDR-mediated inhibition of DKK1 and SFRP2 suppresses adipogenic differentiation of murine bone marrow stromal cells. J Cell Biochem 101:80-88. (Pubitemid 46652574)
22. Dardenne O, Prud'homme J, Arabian A, Glorieux FH, St-Arnaud R. 2001. Targeted inactivation of the 25-hydroxyvitamin D(3)-1(alpha)-hydroxylase gene (CYP27B1) creates an animal model of pseudovitamin D-deficiency rickets. Endocrinology 142:3135-3141.
23. Dardenne O, Prud'homme J, Glorieux FH, St-Arnaud R. 2004. Rescue of the phenotype of CYP27B1 (1alpha-hydroxylase)-deficient mice. J Steroid Biochem Mol Biol 89-90:327-330.
24. Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. 1997. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 337:670-676.
25. Dawson-Hughes B, Chen P, Krege JH. 2007. Response to teriparatide in patients with baseline 25-hydroxyvitamin D insufficiency or sufficiency. J Clin Endocrinol Metab 92:4630-4636.
26. DiMeglio LA. 2000. Disorders of phosphate metabolism. Endocrinol Metab Clin North Amer 29:591-609.
27. DIPART-Group. 2010. Patient level pooled analysis of 68 500 patients from seven major vitamin D fracture trials in US and Europe. Br Med J 340:b5463.
28. Dobnig H, Pilz S, Scharnagl H, Renner W, Seelhorst U, Wellnitz B, Kinkeldei J, Boehm BO, Weihrauch G, Maerz W. 2008. Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch Intern Med 168:1340-1349.
29. Donohue MM, Demay MB. 2002. Rickets in VDR null mice is secondary to decreased apoptosis of hypertrophic chondrocytes. Endocrinology 143: 3691-3694.
30. Ensrud KE, Taylor BC, Paudel ML, Cauley JA, Cawthon PM, Cummings SR, Fink HA, Barrett-Connor E, Zmuda JM, Shikany JM, Orwoll ES. 2009. Serum 25-hydroxyvitamin D levels and rate of hip bone loss in older men. J Clin Endocrinol Metab 94:2773-2780.
31. Erben RG, Soegiarto DW, Weber K, Zeitz U, Lieberherr M, Gniadecki R, Moller G, Adamski J, Balling R. 2002. Deletion of deoxyribonucleic acid binding domain of the vitamin D receptor abrogates genomic and nongenomic functions of vitamin D. Mol Endocrinol 16:1524-1537.
32. Fraser D, Kooh SW, Kind HP, Holick MF, Tanaka Y, DeLuca HF. 1973. Pathogenesis of hereditary vitamin-D-dependent rickets. An inborn error of vitamin D metabolism involving defective conversion of 25-hydroxyvitamin D to 1 alpha,25-dihydroxyvitamin D. N Engl J Med 289:817-822.
33. Gardiner E, Baldock P, Thomas G, Sims N, Henderson N, Hollis B, White C, Sunn K, Morrison N, Walsh W, Eisman J. 2000. Increased formation and decreased resorption of bone in mice with elevated vitamin D receptor in mature cells of the osteoblastic lineage. FASEB J 14:1908-1916.
34. Glerup H, Mikkelsen K, Poulsen L, Hass E, Overbeck S, Andersen H, Charles P, Eriksen EF. 2000a. Hypovitaminosis D myopathy without biochemical signs of osteomalacic bone involvement. Calcif Tissue Int 66:419-424.
35. Glerup H, Mikkelsen K, Poulsen L, Hass E, Overbeck S, Thomsen J, Charles P, Eriksen EF. 2000b. Commonly recommended daily intake of vitamin D is not sufficient if sunlight exposure is limited. J Intern Med 247:260-268.
36. Gordon CM, DePeter KC, Feldman HA, Grace E, Emans SJ. 2004. Prevalence of vitamin D deficiency among healthy adolescents. Arch Pediatr Adolesc Med 158:531-537. (Pubitemid 38720483)
37. Gordon CM, Feldman HA, Sinclair L, Williams AL, Kleinman PK, Perez-Rossello J, Cox JE. 2008. Prevalence of vitamin D deficiency among healthy infants and toddlers. Arch Pediatr Adolesc Med 162:505-512.
38. Grant AM, Avenell A, Campbell MK, McDonald AM, MacLennan GS, McPherson GC, Anderson FH, Cooper C, Francis RM, Donaldson C, Gillespie WJ, Robinson CM, Torgerson DJ, Wallace WA. 2005. Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): A randomised placebo-controlled trial. Lancet 365:1621-1628.
39. Greaves J, Schmidt C. 1933. The role played by bile in the absorption of vitamin D in the rat. J Biol Chem 102:101-112.
40. Guardia G, Parikh N, Eskridge T, Phillips E, Divine G, Rao DS. 2008. Prevalence of vitamin D depletion among subjects seeking advice on osteoporosis: A five-year cross-sectional study with public health implications. Osteoporos Int 19:13-19. (Pubitemid 350198065)
41. Holick MF. 2007. Vitamin D deficiency. N Engl J Med 357:266-281.
42. Holick MF, Garabedian M, DeLuca HF. 1972. 1,25-dihydroxycholecalciferol: Metabolite of vitamin D3 active on bone in anephric rats. Science 176:1146-1147.
43. Holick MF, MacLaughlin JA, Clark MB, Holick SA, Potts JT, Jr., Anderson RR, Blank IH, Parrish JA, Elias P. 1980. Photosynthesis of previtamin D3 in human skin and the physiologic consequences. Science 210:203-205.
44. Holick MF, Siris ES, Binkley N, Beard MK, Khan A, Katzer JT, Petruschke RA, Chen E, de Papp AE. 2005. Prevalence of Vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab 90:3215-3224.
45. Holick MF, Biancuzzo RM, Chen TC, Klein EK, Young A, Bibuld D, Reitz R, Salameh W, Ameri A, Tannenbaum AD. 2008. Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. J Clin Endocrinol Metab 93:677-681.
46. Houghton LA, Vieth R. 2006. The case against ergocalciferol (vitamin D2) as a vitamin supplement. Am J Clin Nutr 84:694-697. (Pubitemid 44715649)
47. Howland J. 1933. The etiology and pathogenesis of rickets. Medicine 2:349-374.
48. Hughes MR, Malloy PJ, Kieback DG, Kesterson RA, Pike JW, Feldman D, O'Malley BW. 1988. Point mutations in the human vitamin D receptor gene associated with hypocalcemic rickets. Science 242:1702-1705.
49. Huhtakangas JA, Olivera CJ, Bishop JE, Zanello LP, Norman AW. 2004. The vitamin D receptor is present in caveolae-enriched plasma membranes and binds 1 alpha,25(OH)2-vitamin D3 in vivo and in vitro. Mol Endocrinol 18:2660-2671.
50. HYP-Consortium. 1995. A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. Nat Genet 11:130-136.
51. Hypponen E, Laara E, Reunanen A, Jarvelin MR, Virtanen SM. 2001. Intake of vitamin D and risk of type 1 diabetes: A birth-cohort study. Lancet 358:1500-1503. (Pubitemid 33055701)
52. Jackson RD, LaCroix AZ, Gass M, Wallace RB, Robbins J, Lewis CE, Bassford T, Beresford SA, Black HR, Blanchette P, Bonds DE, Brunner RL, Brzyski RG, Caan B, Cauley JA, Chlebowski RT, Cummings SR, Granek I, Hays J, Heiss G, Hendrix SL, Howard BV, Hsia J, Hubbell FA, Johnson KC, Judd H, Kotchen JM, Kuller LH, Langer RD, Lasser NL, Limacher MC, Ludlam S, Manson JE, Margolis KL, McGowan J, Ockene JK, O'Sullivan MJ, Phillips L, Prentice RL, Sarto GE, Stefanick ML, Van Horn L, Wactawski-Wende J, Whitlock E, Anderson GL, Assaf AR, Barad D. 2006. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 354:669-683. (Pubitemid 43247138)
53. Jonsson KB, Zahradnik R, Larsson T, White KE, Sugimoto T, Imanishi Y, Yamamoto T, Hampson G, Koshiyama H, Ljunggren O, Oba K, Yang IM, Miyauchi A, Econs MJ, Lavigne J, Juppner H. 2003. Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. N Engl J Med 348:1656-1663. (Pubitemid 36459471)
54. Judd SE, Nanes MS, Ziegler TR, Wilson PW, Tangpricha V. 2008. Optimal vitamin D status attenuates the age-associated increase in systolic blood pressure in white Americans: Results from the third National Health and Nutrition Examination Survey. Am J Clin. Nutr 87:136-141.
55. K/DOQI-Work-Group. 2003. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42:S1-201.
56. Kitanaka STK, Murayama A, Sato T, Okumura K, Nogami M, Hasegawa Y, Niimi H, Yanagisawa J, Tanaka T, Kato S. 1998. Inactivating mutations in the 25-hydroxyvitamin D 1 alpha hydroxylase gene in patients with pseudovitamin D-deficiency rickets. N Engl J Med 338:653-661. (Pubitemid 28108435)
57. Krause R, Buhring M, Hopfenmuller W, Holick MF, Sharma AM. 1998. Ultraviolet B and blood pressure. Lancet 352:709-710.
58. Krishnan AV, Feldman D. 2010. Molecular pathways mediating the anti-inflammatory effects of calcitriol: Implications for prostate cancer chemoprevention and treatment. Endocr Relat Cancer 17:R19-38.
59. Kristjansson K, Rut AR, Hewison M, O'Riordan JL, Hughes MR. 1993. Two mutations in the hormone binding domain of the vitamin D receptor cause tissue resistance to 1,25 dihydroxyvitamin D3. J Clin Invest 92: 12-16. (Pubitemid 23208975)
60. Li YC, Pirro AE, Amling M, Delling G, Baron R, Bronson R, Demay MB. 1997. Targeted ablation of the vitamin D receptor: An animal model of vitamin D-dependent rickets type II with alopecia. Proc Natl Acad Sci USA 94:9831-9835. (Pubitemid 27408150)
61. Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP. 2002. 1,25- Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 110:229-238. (Pubitemid 34787360)
62. Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, Ochoa MT, Schauber J, Wu K, Meinken C, Kamen DL, Wagner M, Bals R, Steinmeyer A, Zugel U, Gallo RL, Eisenberg D, Hewison M, Hollis BW, Adams JS, Bloom BR, Modlin RL. 2006. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311:1770-1773.
63. Looker AC, Dawson-Hughes B, Calvo MS, Gunter EW, Sahyoun NR. 2002. Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. Bone 30:771-777.
64. MacDonald PN, Baudino TA, Tokumaru H, Dowd DR, Zhang C. 2001. Vitamin D receptor and nuclear receptor coactivators: Crucial interactions in vitamin D-mediated transcription. Steroids 66:171-176. (Pubitemid 32143674)
65. Mahon P, Harvey N, Crozier S, Inskip H, Robinson S, Arden N, Swaminathan R, Cooper C, Godfrey K. 2010. Low Maternal Vitamin D Status and Fetal Bone Development: Cohort Study. J Bone Miner Res 25:14-19.
66. Mansfield K, Rajpurohit R, Shapiro I. 1999. Extracellular phosphate ions cause apoptosis of terminally differenitatied epiphyseal chondrocytes. J Cell Physiol 179:276-286. (Pubitemid 29203152)
67. Mansfield K, Teixeira C, Adams C, Shapiro I. 2001. Phosphate ions mediate chondrocyte apoptosis through a plasma membrane transporter mechanism. Bone 28:1-8.
68. Martinez ME, Giovannucci EL, Colditz GA, Stampfer MJ, Hunter DJ, Speizer FE, Wing A, Willett WC. 1996. Calcium, vitamin D, and the occurrence of colorectal cancer among women. J Natl Cancer Inst 88:1375-1382. (Pubitemid 26329755)
69. Masuyama R, Stockmans I, Torrekens S, Van Looveren R, Maes C, Carmeliet P, Bouillon R, Carmeliet G. 2006. Vitamin D receptor in chondrocytes promotes osteoclastogenesis and regulates FGF23 production in osteoblasts. J Clin Invest 116:3150-3159.
70. McCollum EV, Simmonds N, Parsons HT, Shipley PG, Park EA. 1921. Studies on experimental rickets: I. The production of rachitis and similar diseases in the rat by deficient diets. J Biol Chem 45:333-341.
71. Melamed ML, Michos ED, Post W, Astor B. 2008. 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 168:1629-1637.
72. Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A. 2006. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 296:2832-2838. (Pubitemid 44969183)
73. Naja RP, Dardenne O, Arabian A, St Arnaud R. 2009. Chondrocyte-specific modulation of Cyp27b1 expression supports a role for local synthesis of 1,25-dihydroxyvitamin D3 in growth plate development. Endocrinology 150: 4024-4032.
74. National-Academy-of-Sciences. 2009. National Academy of Sciences web based press release. Institute of Medicine of the National Academies: Dietary Reference Intakes for Vitamin D and Calcium Committee National Academy of Sciences.
75. Nesby-O'Dell S, Scanlon KS, Cogswell ME, Gillespie C, Hollis BW, Looker AC, Allen C, Doughertly C, Gunter EW, Bowman BA. 2002. Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: Third National Health and Nutrition Examination Survey, 1988-1994. Am J Clin Nutr 76:187-192.
76. Norman AW. 1998. Sunlight, season, skin pigmentation, vitamin D, and 25-hydroxyvitamin D: Integral components of the vitamin D endocrine system. Am J Clin Nutr 67:1108-1110.
77. Ooms ME, Roos JC, Bezemer PD, van der Vijgh WJ, Bouter LM, Lips P. 1995. Prevention of bone loss by vitamin D supplementation in elderly women: A randomized double-blind trial. J Clin Endocrinol Metab 80:1052-1058.
78. Orwoll E, Nielson CM, Marshall LM, Lambert L, Holton KF, Hoffman AR, Barrett-Connor E, Shikany JM, Dam T, Cauley JA. 2009. Vitamin D deficiency in older men. J Clin Endocrinol Metab 94:1214-1222.
79. Owen TA, Bortell R, Yocum SA, Smock SL, Zhang M, Abate C, Shalhoub V, Aronin N, Wright KL, van Wijnen AJ, Stein JL, Curran T, Lian JB, Stein GS. 1990. Coordinate occupancy of AP-1 sites in the vitamin D-responsive and CCAAT box elements by Fos-Jun in the osteocalcin gene: Model for phenotype suppression of transcription. Proc Natl Acad Sci USA 87:9990-9994.
80. Pettifor JM. 2005a. Vitamin D deficiency and nutritional rickets in children. In: Feldman D, Pike JW, Glorieux FH, editors. Vitamin D. London: Elsevier Academic Press. pp. 1065-1067.
81. Pettifor JM. 2005b. Vitamin D deficiency and nutritional rickets in children. In: Feldman D, Pike JW, Glorieux FH, editors. Vitamin D. London: Elsevier Academic Press. pp. 1070-1071.
82. Pfeifer M, Begerow B, Minne HW. 2002. Vitamin D and muscle function. Osteoporos Int 13:187-194.
83. Pietras SM, Obayan BK, Cai MH, Holick MF. 2009. Vitamin D2 treatment for vitamin D deficiency and insufficiency for up to 6 years. Arch Intern Med 169:1806-1808.
84. Pittas AG, Lau J, Hu FB, Dawson-Hughes B. 2007. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 92:2017-2029. (Pubitemid 46997093)
85. Sabbagh Y, Carpenter TO, Demay M. 2005. Hypophosphatemia leads to rickets by impairing caspase-mediated apoptosis of hypertrophic chondrocytes. Proc Natl Acad Sci 102:9637-9642. (Pubitemid 40981733)
86. Shipley PG, Park EA, McCollum EV, Simmonds N, Parsons HT. 1921. Studies on experimental rickets: II. The effect of cod liver oil administered to rats with experimental rickets. J Biol Chem 45:343-348.
87. Sooy K, Sabbagh Y, Demay MB. 2005. Osteoblasts lacking the vitamin D receptor display enhanced osteogenic potential in vitro. J Cell Biochem 94: 81-87.
88. St-Arnaud R, Messerlian S, Moir JM, Omdahl JL, Glorieux FH. 1997. The 25-hydroxyvitamin D 1-alpha-hydroxylase gene maps to the pseudovitamin D-deficiency rickets (PDDR) disease locus. J Bone Miner Res 12:1552-1559.
89. Takeda S, Yoshizawa T, Nagai Y, Yamato H, Fukumoto S, Sekine K, Kato S, Matsumoto T, Fujita T. 1999. Stimulation of Osteoclast Formation by 1,25-dihydroxyvitamin D requires its binding to Vitamin D receptor (VDR) in osteoblastic cells: Studies using VDR Knockout mice. Endocrinology 140: 1005-1008.
90. Tangpricha V, Flanagan JN, Whitlatch LW, Tseng CC, Chen TC, Holt PR, Lipkin MS, Holick MF. 2001. 25-hydroxyvitamin D-1alpha-hydroxylase in normal and malignant colon tissue. Lancet 357:1673-1674.
91. Thomas M, Demay M. 2000. Vitamin D Deficiency and disorders of Vitamin D metabolism. Endocrinol Metab Clin North Am 29:611-627.
92. Trang HM, Cole DE, Rubin LA, Pierratos A, Siu S, Vieth R. 1998. Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2. Am J Clin Nutr 68:854-858. (Pubitemid 28471068)
93. Vieth R. 2004. Why the optimal requirement for Vitamin D3 is probably much higher than what is officially recommended for adults. J Steroid Biochem Mol Biol 89-90:575-579.
94. Viljakainen HT, Vaisanen M, Kemi V, Rikkonen T, Kroger H, Laitinen EK, Rita H, Lamberg-Allardt C. 2009. Wintertime vitamin D supplementation inhibits seasonal variation of calcitropic hormones and maintains bone turnover in healthy men. J Bone Miner Res 24:346-352.
95. Weng FL, Shults J, Leonard MB, Stallings VA, Zemel BS. 2007. Risk factors for low serum 25-hydroxyvitamin D concentrations in otherwise healthy children and adolescents. Am J Clin Nutr 86:150-158.
96. Wilkinson RJ, Llewelyn M, Toossi Z, Patel P, Pasvol G, Lalvani A, Wright D, Latif M, Davidson RN. 2000. Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: A case-control study. Lancet 355:618-621.
97. Wong RG, Norman AW, Reddy CR, Coburn JW. 1972. Biologic effects of 1,25-dihydroxycholecalciferol (a highly active vitamin D metabolite) in acutely uremic rats. J Clin Invest 51:1287-1291.